LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid Saliva Tests as Good as PCR Tests for Diagnosing COVID-19 in Early Phase of Infection

By LabMedica International staff writers
Posted on 11 Nov 2021
Print article
Illustration
Illustration

Researchers investigating whether rapid antigen testing can be used on saliva instead of swabbing the nasal cavity have found that saliva can be good enough for diagnosing COVID-19 in the early phase of infection.

The study from Lund University (Lund, Sweden) aimed to find out if rapid COVID-19 tests using saliva could be easier alternatives to the common PCR tests which involve a nose and throat sample taken with a cotton swab - a procedure that is often unpleasant. Quick diagnostic tools are crucial in reducing the spread of COVID-19. Today, there are several different test methods to identify an ongoing infection. The PCR tests used in healthcare and most commercially available antigen tests are usually taken with swabs in the nasal cavity - a method that many find uncomfortable. Antigen tests are used as a complement to PCR testing when increased test capacity or rapid test results are required. However, there are also saliva tests.

In the current study, the researchers compared RT-PCR tests with saliva samples they collected from 44 patients. All 44 participants had confirmed COVID-19, and had to clear their throat before spitting. The results showed that coronavirus can be detected in both saliva and nasal cavity samples, but that the concentrations are slightly lower in saliva. The researchers also examined four different rapid antigen tests available on the market, to see how well they detect the virus in saliva samples. All four antigen tests were found to be relatively sensitive in detecting the virus early in the infection, as the virus concentration is higher at that point. Later in the infection, when the virus concentration is lower, the antigen tests were not sufficiently sensitive. The researchers believe that rapid saliva tests are a good alternative to standard PCR testing, and can also supplement these methods as screening needs increase.

“Although our study isn’t definitive, our results indicate that rapid tests using saliva might be good enough for diagnosing COVID-19 in the early phase of infection”, said Magnus Rasmussen, specialist in infectious disease medicine at Skåne University Hospital and professor at Lund University, who led the study.

“The advantage of a saliva-based rapid test is that you can easily take it at home in peace and quiet. For many, it can make a big difference. If infection occurs in, for example, primary school, the younger unvaccinated students can be screened more quickly with a saliva-based rapid test. For children, it is important that sampling is simple and without discomfort”, added Yang de Marinis, who is the first author of the study.

Related Links:
Lund University 

Platinum Member
SARS-CoV-2 Reactive & Non-Reactive Controls
Qnostics SARS-CoV-2 Typing
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 TEST READER
COVID-19-CHECK-1 EASY READER+

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Signs of multiple sclerosis show up in blood years before symptoms appear (Photo courtesy of vitstudio/Shutterstock)

Unique Autoantibody Signature to Help Diagnose Multiple Sclerosis Years before Symptom Onset

Autoimmune diseases such as multiple sclerosis (MS) are thought to occur partly due to unusual immune responses to common infections. Early MS symptoms, including dizziness, spasms, and fatigue, often... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: Microscope image showing human colorectal cancer tumor with Fusobacterium nucleatum stained in a red-purple color (Photo courtesy of Fred Hutch Cancer Center)

Mouth Bacteria Test Could Predict Colon Cancer Progression

Colon cancer, a relatively common but challenging disease to diagnose, requires confirmation through a colonoscopy or surgery. Recently, there has been a worrying increase in colon cancer rates among younger... Read more

Pathology

view channel
Image: A new study has identified patterns that predict ovarian cancer relapse (Photo courtesy of Cedars-Sinai)

Spatial Tissue Analysis Identifies Patterns Associated With Ovarian Cancer Relapse

High-grade serous ovarian carcinoma is the most lethal type of ovarian cancer, and it poses significant detection challenges. Typically, patients initially respond to surgery and chemotherapy, but the... Read more